Cargando…
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial
This study aimed to validate previously reported dosimetric parameters, including thyroid volume, mean dose, and percentage thyroid volume, receiving at least 40, 45 and 50 Gy (V40, V45 and V50), absolute thyroid volume spared (VS) from 45, 50 and 60 Gy (VS45, VS50 and VS60), and clinical factors af...
Autores principales: | Lertbutsayanukul, Chawalit, Kitpanit, Sarin, Prayongrat, Anussara, Kannarunimit, Danita, Netsawang, Buntipa, Chakkabat, Chakkapong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054176/ https://www.ncbi.nlm.nih.gov/pubmed/29750261 http://dx.doi.org/10.1093/jrr/rry036 |
Ejemplares similares
-
Prognostic Value of Plasma EBV DNA for Nasopharyngeal Cancer Patients during Treatment with Intensity-modulated Radiation Therapy and Concurrent Chemotherapy
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018) -
Improved prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma using pre-treatment CT radiomics
por: Ritlumlert, Napat, et al.
Publicado: (2023) -
Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer
por: Oonsiri, Sornjarod, et al.
Publicado: (2022) -
Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
por: Prayongrat, Anussara, et al.
Publicado: (2017) -
A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events
por: Songthong, Anussara P., et al.
Publicado: (2015)